DK3525807T3 - Hæmmer af rna-polymerase ii - Google Patents
Hæmmer af rna-polymerase ii Download PDFInfo
- Publication number
- DK3525807T3 DK3525807T3 DK17797991.1T DK17797991T DK3525807T3 DK 3525807 T3 DK3525807 T3 DK 3525807T3 DK 17797991 T DK17797991 T DK 17797991T DK 3525807 T3 DK3525807 T3 DK 3525807T3
- Authority
- DK
- Denmark
- Prior art keywords
- inhibitors
- rna polymerase
- polymerase
- rna
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/44—Oxidoreductases (1)
- A61K38/443—Oxidoreductases (1) acting on CH-OH groups as donors, e.g. glucose oxidase, lactate dehydrogenase (1.1)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/91—Transferases (2.)
- G01N2333/912—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- G01N2333/91205—Phosphotransferases in general
- G01N2333/91245—Nucleotidyltransferases (2.7.7)
- G01N2333/9125—Nucleotidyltransferases (2.7.7) with a definite EC number (2.7.7.-)
- G01N2333/91255—DNA-directed RNA polymerase (2.7.7.6)
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Mycology (AREA)
- Pathology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1617548.1A GB201617548D0 (en) | 2016-10-17 | 2016-10-17 | Novel biological factor |
PCT/IB2017/056413 WO2018073725A1 (en) | 2016-10-17 | 2017-10-16 | Inhibitor of rna polymerase ii |
Publications (1)
Publication Number | Publication Date |
---|---|
DK3525807T3 true DK3525807T3 (da) | 2022-02-14 |
Family
ID=57680807
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK17797991.1T DK3525807T3 (da) | 2016-10-17 | 2017-10-16 | Hæmmer af rna-polymerase ii |
Country Status (7)
Country | Link |
---|---|
US (2) | US20190240287A1 (da) |
EP (1) | EP3525807B1 (da) |
AU (1) | AU2017344453A1 (da) |
DK (1) | DK3525807T3 (da) |
GB (1) | GB201617548D0 (da) |
SG (1) | SG11201903336UA (da) |
WO (1) | WO2018073725A1 (da) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB201617548D0 (en) * | 2016-10-17 | 2016-11-30 | Linnane Pharma Ab | Novel biological factor |
US11541105B2 (en) | 2018-06-01 | 2023-01-03 | The Research Foundation For The State University Of New York | Compositions and methods for disrupting biofilm formation and maintenance |
CN114230666B (zh) * | 2021-12-20 | 2022-09-02 | 南京诺唯赞生物科技股份有限公司 | 一种t7 rna聚合酶的单克隆抗体及其制备方法 |
GB202201139D0 (en) * | 2022-01-28 | 2022-03-16 | Selectimmune Pharma Ab | Therapeutic agent |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7319026B2 (en) * | 2002-03-07 | 2008-01-15 | Degussa Ag | Amino acid-producing bacteria and a process for preparing L-amino acids |
AU2006214064B2 (en) * | 2005-02-18 | 2012-04-26 | J. Craig Venter Institute, Inc. | Proteins and nucleic acids from meningitis/sepsis-associated escherichia coli |
US20100047861A1 (en) * | 2005-09-29 | 2010-02-25 | Kiyotaka Hara | Process for producing useful substance |
US9630950B2 (en) | 2007-04-23 | 2017-04-25 | California Institute Of Technology | Inhibitors for steroid response elements and RNA polymerase II and related methods |
US20160220687A1 (en) | 2015-02-02 | 2016-08-04 | National Guard Health Affairs | Metalloproteinase-cleavable alpha-amanitin-dendrimer conjugates and method of treating cancer |
WO2016193939A1 (en) | 2015-06-04 | 2016-12-08 | Aurigene Discovery Technologies Limited | Substituted heterocyclyl derivatives as cdk inhibitors |
GB201617548D0 (en) * | 2016-10-17 | 2016-11-30 | Linnane Pharma Ab | Novel biological factor |
-
2016
- 2016-10-17 GB GBGB1617548.1A patent/GB201617548D0/en not_active Ceased
-
2017
- 2017-10-16 EP EP17797991.1A patent/EP3525807B1/en active Active
- 2017-10-16 SG SG11201903336UA patent/SG11201903336UA/en unknown
- 2017-10-16 WO PCT/IB2017/056413 patent/WO2018073725A1/en active Application Filing
- 2017-10-16 DK DK17797991.1T patent/DK3525807T3/da active
- 2017-10-16 US US16/341,962 patent/US20190240287A1/en not_active Abandoned
- 2017-10-16 AU AU2017344453A patent/AU2017344453A1/en active Pending
-
2020
- 2020-09-25 US US17/032,308 patent/US11752192B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
US20210069291A1 (en) | 2021-03-11 |
US20190240287A1 (en) | 2019-08-08 |
WO2018073725A1 (en) | 2018-04-26 |
US11752192B2 (en) | 2023-09-12 |
SG11201903336UA (en) | 2019-05-30 |
EP3525807A1 (en) | 2019-08-21 |
GB201617548D0 (en) | 2016-11-30 |
AU2017344453A1 (en) | 2019-04-18 |
EP3525807B1 (en) | 2021-12-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK3445850T3 (da) | Fremgangsmåder til tilvejebringelse af enkeltstrenget rna | |
DK3512850T3 (da) | Inhibitorer af menin-mll-interaktionen | |
DK3433368T3 (da) | Transreplikerende rna | |
DK3468966T3 (da) | Inhibitorer af menin-mll-interaktionen | |
DK3377059T3 (da) | Hæmmere af cxcr2 | |
DK3442972T3 (da) | Bromdomænehæmmere | |
CL2016002502A1 (es) | Inhibidores de biaril cinasa | |
DK3134506T3 (da) | Fremgangsmåder til oprensning af messenger rna | |
DK3102576T3 (da) | Dihydropyrrolopyridininhibitorer af ror-gamma | |
DK3466432T3 (da) | Fremgangsmåder til behandling af pulmonale non-tuberkuløse mykobakterielle infektioner | |
DK3164380T3 (da) | Hæmmere af lysinspecifik demethylase-1 | |
DK3201361T3 (da) | Fremgangsmåder til kvantificering af cellefrit DNA | |
MA54568A (fr) | Substitutions de nucléotides prédéterminées | |
DK3351633T3 (da) | Antisense-nukleinsyre | |
DK3728585T3 (da) | Hidtil ukendte fremgangsmåder til fremstilling af oligonukleotider | |
MA42692A (fr) | Compositions biopharmaceutiques | |
MA43367A (fr) | Inhibiteurs de métallo-bêta-lactamases | |
DK3341379T3 (da) | EZH2-hæmmere | |
DK3523315T3 (da) | Inhibitor af glucocorticoidreceptor | |
DK3114235T3 (da) | Fremgangsmåde til bestemmelse af risiko for 5-fluorouracil-toksicitet | |
MA46280A (fr) | Inhibiteurs de la dopamine-b-hydroxylase | |
DK3380982T3 (da) | Håndtering af genom forespørgsel | |
DK3307436T3 (da) | Mikrofluidanordning | |
DK3329007T3 (da) | Ortogonal afblokering af nukleotider | |
DK3204352T3 (da) | Hæmmere af lysin-gingipain |